As advancements in medical technology continue to shape the healthcare landscape, DexCom, Inc. (DXCM) stands out with its innovative continuous glucose monitoring solutions. Recent price action suggests that DXCM’s stock price has triggered a potentially new bullish run. In this article, I will examine the technical and fundamental factors behind this positive outlook and outline a risk-defined options strategy — all identified via the OptionsPlay Strategy Center within StockCharts.com. After consolidating between $75 and $80 over the past two months, DXCM’s stock price recently broke out of this trading range with impressive relative strength. Range Breakout. The stock’s breakout above $80 marks a decisive breakout from its consolidation zone. Outperformance. The breakout has been coupled with outperformance to the S&P 500. Upside Target. Given the breakout, there is potential for DXCM’s stock price to fill the gap up to the $107.50 level. FIGURE 1. DAILY CHART OF DXCM STOCK. The…